Novel self-assembling nanoparticle from irinotecan shows high anti-tumor efficacy in pancreatic cancer

被引：0
|
作者：
Zhang, L. [1 ]
Wang, W. [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
来源：
TRANSPLANTATION | 2018年 / 102卷
关键词：
Nanoparticle; irinotecan; pancreatic cancer;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-273
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [31] Novel Self-Assembled Micelles With Increased Tumor Penetration and Anti-Tumor Efficiency Against Breast Cancer
    Yang, Yani
    Zhao, Yuezhu
    Liu, Jie
    Ge, Chen
    Zhang, Weiwei
    Zhang, Yue
    Wang, Junji
    Sun, Guohao
    Lin, Xiujun
    Lu, Xiaohong
    Tang, Xiang
    He, Jun
    Lu, Weigen
    Qin, Jing
    PHARMACEUTICAL RESEARCH, 2022, 39 (09) : 2227 - 2246
  • [32] PEGylated TRAIL/Apo2L shows greatly improved circulating half life and improved anti-tumor efficacy in xenograft models for colon and pancreatic cancer
    Biroc, Sandra L.
    Brin, Elena
    Knudsen, Nick
    Marsden, Robin
    de Dios, Kristine
    Hewet, Amha G.
    Pinkstaff, Jason
    Kraynov, Vadim
    CANCER RESEARCH, 2011, 71
  • [33] PDLLA length on anti-breast cancer efficacy of acid-responsive self-assembling mPEG-PDLLA–docetaxel conjugates
    Tao Liu
    Hui Zou
    Jingqing Mu
    Xi Zhang
    Guohua Liu
    Na Yu
    Bo Yuan
    Xiaoyong Yuan
    Xingjie Liang
    Shutao Guo
    Chinese Chemical Letters, 2023, 34 (09) : 243 - 247
  • [34] PDLLA length on anti-breast cancer efficacy of acid-responsive self-assembling mPEG-PDLLA-docetaxel conjugates
    Liu, Tao
    Zou, Hui
    Mu, Jingqing
    Zhang, Xi
    Liu, Guohua
    Yu, Na
    Yuan, Bo
    Yuan, Xiaoyong
    Liang, Xingjie
    Guo, Shutao
    CHINESE CHEMICAL LETTERS, 2023, 34 (09)
  • [35] A novel ALK5 inhibitor, AL2 shows anti-tumor activity by modulating cancer immunity
    Sawa, Masaaki
    Arai, Mai
    Hanada, Mitsuharu
    Moriyama, Hideki
    Ohmoto, Hiroshi
    Naka, Kazuhito
    CANCER SCIENCE, 2024, 115 : 287 - 287
  • [36] MDX-124, a novel annexin-A1 antibody, shows anti-tumor efficacy in several preclinical models of triple-negative breast cancer
    Dempsey, Fiona C.
    Al-Ali, Hussein
    Crichton, Scott J.
    Fabian, Charlene
    Pepper, Chris
    Parris, Christopher N.
    CANCER RESEARCH, 2022, 82 (04)
  • [37] Preclinical anti-tumor activity of nanoliposomal irinotecan (Nal-IRI, MM-398) 5-FU + oxaliplatin in pancreatic cancer
    Gaddy, Daniel F.
    Lee, Helen
    Paz, Nancy
    Leonard, Shannon C.
    Kalra, Ashish
    Straubinger, Ninfa L.
    Straubinger, Robert M.
    Gillard, Bryan M.
    Moser, Michael T.
    Drummond, Daryl C.
    Klinz, Stephan G.
    Hendriks, Bart S.
    Fitzgerald, Jonathan B.
    CANCER RESEARCH, 2016, 76
  • [38] The potent quadruplex-binding compound SOP1812 shows anti-tumor activity in patientderived in vivo models of pancreatic cancer
    Neidle, Stephen
    Ahmed, Ahmed
    Angell, Richard
    Oxenford, Sally
    CANCER RESEARCH, 2022, 82 (12)
  • [39] A novel anti-angiogenesis peptide in combination with cisplatin self-assembling into tube-like nanomedicine for oral treatment of gastric cancer
    Chen, Linwei
    Wang, Qin
    Jiang, Yong
    Xu, Liu
    Wei, Nina
    Lu, Chang
    Chang, Chenqi
    Song, Dandan
    Wang, Yutong
    Wu, Li
    Li, Weidong
    Jia, Xiaobin
    Zhao, Kaijun
    Hua, Haibing
    Chen, Rui
    Chen, Zhipeng
    CHEMICAL ENGINEERING JOURNAL, 2024, 496
  • [40] INFECTIVITY-ENHANCED ONCOLYTIC ADENOVIRAL VECTORS EXPRESSING SYNGENEIC IFNα SHOWS STRONG ANTI-TUMOR EFFECT FOR PANCREATIC CANCER.
    Davydova, Julia
    Brown, Eric
    Vickers, Selwyn
    Yamamoto, Masato
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1033 - 1033
12345